Dr. Heather D. Mannuel, MD

Dr. Mannuel practices at University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System.

Dr. Mannuel's NPI, 1720047129, was assigned on March 23, 2006. Dr. Mannuel graduated from University of Maryland School of Medicine in 1998. Dr. Mannuel holds Maryland license D0057936.

Dr. Mannuel's primary practice is University of Maryland Medical Center, at 22 South Greene Street, Baltimore, MD 21201 in Baltimore City. The practice phone is (410) 328-8667.

Dr. Mannuel's primary practice is University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System. The medical group on file is University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mannuel practices. Vendor and product names are available with a free account.

Medical oncology is Dr. Mannuel's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Mannuel is licensed in Maryland.

CMS data shows 422 Medicare services from Dr. Mannuel across 5 procedure codes in 2024, for 116 Medicare patients. Medicare paid $31,112 for them.

CMS counts 116 Medicare patients who saw Dr. Mannuel in 2024. The largest group is 75 to 84, with 55 patients. 75% of them have cancer, and 75% have high blood pressure. 16% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mannuel's median patient age at 70, with 8% women.

In 2024, Dr. Mannuel wrote 704 Medicare Part D claims for 57 patients. 85% of them were for generic drugs. CMS names the drug for 563 of them, across 19 drugs with 11 or more claims each, at $1,474,912 in total drug cost. In 2023, CMS named 378 claims across 10 drugs.

Dr. Mannuel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mannuel as offering telehealth.

Dmand AI links 13 papers to Dr. Mannuel, published from 2014 to 2024. 2019 was the busiest year, with 2. The most frequent topics are Antibodies, Viral, COVID-19 and Prostatic Neoplasms. Dr. Mannuel has published most often in Curr Opin Oncol. Dr. Mannuel's most frequent co-authors are Djordje Atanackovic, MD, Arif Hussain, MD and Aaron Paul Rapoport, MD.

Dmand AI links Dr. Mannuel to 4 clinical trials, 2 of them phase 2 studies. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell and Neoplasms, Squamous Cell.

CMS Open Payments shows 19 general payments to Dr. Mannuel from 10 drug and device companies from 2016 to 2024. Education make up the largest share, 50% of the total. Sanofi and Genzyme US Companies paid the most, $275.

Dr. Mannuel graduated from University of Maryland School of Medicine in 1998.